Suppr超能文献

通过患者及利益相关者参与为新冠病毒感染的自我隔离患者实施远程随访患者门户网站(蛋白石-新冠研究):混合方法试点研究

Implementing a Patient Portal for the Remote Follow-Up of Self-Isolating Patients With COVID-19 Infection Through Patient and Stakeholder Engagement (the Opal-COVID Study): Mixed Methods Pilot Study.

作者信息

Ma Yuanchao, Lessard David, Vicente Serge, Engler Kim, Rodriguez Cruz Adriana, Laymouna Moustafa, Hijal Tarek, Del Balso Lina, Thériault Guillaume, Paisible Nathalie, Kronfli Nadine, Pomey Marie-Pascale, Peiris Hansi, Barkati Sapha, Brouillette Marie-Josée, Klein Marina, Cox Joseph, de Pokomandy Alexandra, Asselah Jamil, Bartlett Susan J, Lebouché Bertrand

机构信息

Center of Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.

Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.

出版信息

J Particip Med. 2024 Dec 4;16:e48194. doi: 10.2196/48194.

Abstract

BACKGROUND

The COVID-19 pandemic was an unprecedent challenge to public health systems, with 95% of cases in Quebec sent home for self-isolation. To ensure continuous care, we implemented an intervention supported by a patient portal (Opal) to remotely monitor at-home patients with COVID-19 via daily self-reports of symptoms, vital signs, and mental health that were reviewed by health care professionals.

OBJECTIVE

We describe the intervention's implementation, focusing on the (1) process; (2) outcomes, including feasibility, fidelity, acceptability, usability, and perceived response burden; and (3) barriers and facilitators encountered by stakeholders.

METHODS

The implementation followed a co-design approach operationalized through patient and stakeholder engagement. The intervention included a 14-day follow-up for each patient. In the mixed methods study at the McGill University Health Centre in Montreal, Quebec, participants completed questionnaires on implementation outcomes on days 1, 7, and 14. All scores were examined against predefined success thresholds. Linear mixed models and generalized estimating equations were used to assess changes in scores over time and whether they differed by sex, age, and race. Semistructured interviews were conducted with expert patients, health care professionals, and coordinators for the qualitative analysis and submitted to thematic analysis guided by the Consolidated Framework for Implementation Research.

RESULTS

In total, 51 participants were enrolled between December 2020 and March 2021; 49 (96%) were included in the quantitative analysis. Observed recruitment and retention rates (51/52, 98% and 49/51, 96%) met the 75% feasibility success threshold. Over 80% of the participants found it "quite easy/very easy" to complete the daily self-report, with a completion rate (fidelity) of >75% and a nonsignificant decreasing trend over time (from 100%, 49/49 to 82%, 40/49; P=.21). Mean acceptability and usability scores at all time points exceeded the threshold of 4 out of 5. Acceptability scores increased significantly between at least 2 time points (days 1, 7, and 14: mean 4.06, SD 0.57; mean 4.26, SD 0.59; and mean 4.25, SD 0.57; P=.04). Participants aged >50 years reported significantly lower mean ease of use (usability) scores than younger participants (days 1, 7, and 14: mean 4.29, SD 0.91 vs mean 4.67, SD 0.45; mean 4.13, SD 0.89 vs mean 4.77, SD 0.35; and mean 4.24, SD 0.71 vs mean 4.72, SD 0.71; P=.004). In total, 28 stakeholders were interviewed between June and September 2021. Facilitators included a structured implementation process, a focus on stakeholders' recommendations, the adjustability of the intervention, and the team's emphasis on safety. However, Opal's thorough privacy protection measures and limited acute follow-up capacities were identified as barriers, along with implementation delays due to data security-related institutional barriers.

CONCLUSIONS

The intervention attained targets across all studied implementation outcomes. Qualitative findings highlighted the importance of stakeholder engagement. Telehealth tools have potential for the remote follow-up of acute health conditions.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/35760.

摘要

背景

新冠疫情对公共卫生系统构成了前所未有的挑战,魁北克省95%的病例被送回家中进行自我隔离。为确保持续护理,我们实施了一项由患者门户网站(Opal)支持的干预措施,通过患者每日自我报告症状、生命体征和心理健康状况,由医护人员进行审核,从而对新冠居家患者进行远程监测。

目的

我们描述该干预措施的实施情况,重点关注(1)过程;(2)结果,包括可行性、保真度、可接受性、可用性和感知反应负担;以及(3)利益相关者遇到的障碍和促进因素。

方法

该实施采用了通过患者和利益相关者参与实现的协同设计方法。干预措施包括对每位患者进行14天的随访。在魁北克省蒙特利尔市麦吉尔大学健康中心进行的混合方法研究中,参与者在第1天、第7天和第14天完成了关于实施结果的问卷调查。所有分数均对照预先设定的成功阈值进行检查。使用线性混合模型和广义估计方程来评估分数随时间的变化以及它们是否因性别、年龄和种族而异。对专家患者、医护人员和协调员进行了半结构化访谈,以进行定性分析,并提交给以实施研究综合框架为指导的主题分析。

结果

2020年12月至2021年3月期间共招募了51名参与者;49名(96%)纳入定量分析。观察到的招募和留存率(51/52,98%和49/51,96%)达到了75%的可行性成功阈值。超过80%的参与者认为完成每日自我报告“相当容易/非常容易”,完成率(保真度)>75%,且随时间呈非显著下降趋势(从100%,49/49降至82%,40/49;P = 0.21)。所有时间点的平均可接受性和可用性分数均超过了5分制中4分的阈值。可接受性分数在至少两个时间点之间显著增加(第1天、第7天和第14天:平均4.06,标准差0.57;平均4.26,标准差0.59;平均4.25,标准差0.57;P = 0.04)。年龄>50岁的参与者报告的平均易用性(可用性)分数显著低于年轻参与者(第1天、第7天和第14天:平均4.29,标准差0.91对平均4.67,标准差0.45;平均4.13,标准差0.89对平均4.77,标准差0.35;平均4.24,标准差0.71对平均4.72,标准差0.71;P = 0.004)。2021年6月至9月期间共采访了28名利益相关者。促进因素包括结构化的实施过程、对利益相关者建议的关注、干预措施的可调整性以及团队对安全性的重视。然而,Opal全面的隐私保护措施和有限的急性随访能力被确定为障碍,同时还存在因数据安全相关的机构障碍导致的实施延迟。

结论

该干预措施在所有研究的实施结果方面均达到了目标。定性研究结果突出了利益相关者参与的重要性。远程医疗工具在急性健康状况的远程随访方面具有潜力。

国际注册报告识别码(IRRID):RR2-10.2196/35760。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c99/11656113/1e86a2c392c4/jopm_v16i1e48194_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验